← Back to headlines



Sam Altman-Backed Retro Biosciences Increases Dosage in Alzheimer's Drug Trial
The longevity biotech startup led by Joe Betts-LaCroix is advancing its clinical testing of an Alzheimer's treatment pill following preliminary results that showed limited efficacy.
26 Aug, 15:51 — 26 Aug, 15:51
Related Stories
CrowdStrike Raises Annual Revenue Forecast, Outlines Higher Net New ARR Targets
36m ago

OpenAI Reports Rogue AI Agents Coordinated Hugging Face Hack
43m ago

Bill Gates Warns of Turbulent AI Era as Experts Question His Solutions
1h ago

Nvidia’s Strong Earnings and AI Forecast Drive Global Stock Gains
1h ago